Related Experiment Video
Updated: May 18, 2026

Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
PEP-1-p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression
Duk-Soo Kim1, Eun Jeong Sohn, Dae Won Kim
1Department of Anatomy, College of Medicine, Soonchunhyang University, Cheonan 330-090, Korea.
Abstract:
P18, a member of the INK4 family of cyclin-dependent kinase inhibitors, is a tumor suppressor protein and plays a key cell survival role in a variety of human cancers. Under pathophysiological conditions, the INK4 group proteins participate in novel biological functions associated with neuronal diseases and oxidative stress. Parkinson's disease (PD) is characterized by loss of dopaminergic neurons, and oxidative stress is important in its pathogenesis. Therefore, we examined the effects of PEP-1-p18 on oxidative stress-induced SH-SY5Y cells and in a PD mouse model. The transduced PEP-1-p18 markedly inhibited 1-methyl-4-phenyl pyridinium-induced SH-SY5Y cell death by inhibiting Bax expression levels and DNA fragmentation. Additionally, PEP-1-p18 prevented dopaminergic neuronal cell death in the substantia nigra of a 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-induced PD mouse model. These results indicate that PEP-1-p18 may be a useful therapeutic agent against various diseases and is a potential tool for treating PD.
Insights
PEP-1-p18, a tumor suppressor, protected against oxidative stress in Parkinson
Area of Science:
- Molecular Biology
- Neuroscience
- Oncology
Background:
- P18, an INK4 family cyclin-dependent kinase inhibitor, functions as a tumor suppressor and promotes cell survival in cancers.
- INK4 proteins are implicated in neuronal diseases and oxidative stress, key factors in Parkinson's disease (PD) pathogenesis.
- Oxidative stress contributes significantly to the loss of dopaminergic neurons observed in PD.
Purpose of the Study:
- To investigate the protective effects of PEP-1-p18 against oxidative stress in neuronal cells.
- To evaluate PEP-1-p18's efficacy in a mouse model of Parkinson's disease.
Main Methods:
- Utilized SH-SY5Y cells exposed to oxidative stress induced by 1-methyl-4-phenyl pyridinium (MPP+).
- Administered PEP-1-p18 to assess its impact on cell viability and apoptosis markers (Bax expression, DNA fragmentation).
- Employed a 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP)-induced PD mouse model to evaluate neuroprotection in vivo.
Main Results:
- PEP-1-p18 significantly inhibited MPP+-induced SH-SY5Y cell death by reducing Bax expression and DNA fragmentation.
- Transduced PEP-1-p18 treatment prevented dopaminergic neuronal cell loss in the substantia nigra of MPTP-treated mice.
- Demonstrated a neuroprotective effect of PEP-1-p18 in a relevant Parkinson's disease model.
Conclusions:
- PEP-1-p18 exhibits significant protective effects against oxidative stress-induced neuronal cell death.
- PEP-1-p18 demonstrates therapeutic potential for Parkinson's disease by preserving dopaminergic neurons.
- PEP-1-p18 may serve as a valuable therapeutic agent for various diseases involving oxidative stress.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Cell Specific Gene Expression
Negative Regulator Molecules